The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?
Open accessAbstract
Co-infection has been reported in patients with severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome, but there is limited knowledge on co-infection among patients with coronavirus disease 2019 (COVID-19). The prevalence of co-infection was variable among COVID-19 patients in different studies, however, it could be up to 50% among non-survivors. Co-pathogens included bacteria, such as Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae, Mycoplasma pneumoniae, Chlamydia pneumonia, Legionella pneumophila and Acinetobacter baumannii; Candida species and Aspergillus flavus; and viruses such as influenza, coronavirus, rhinovirus/enterovirus, parainfluenza, metapneumovirus, influenza B virus, and human immunodeficiency virus. Influenza A was one of the most common co-infective viruses, which may have caused initial false-negative results of real-time reverse-transcriptase polymerase chain reaction for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Laboratory and imaging findings alone cannot help distinguish co-infection from SARS-CoV-2 infection. Newly developed syndromic multiplex panels that incorporate SARS-CoV-2 may facilitate the early detection of co-infection among COVID-19 patients. By contrast, clinicians cannot rule out SARS-CoV-2 infection by ruling in other respiratory pathogens through old syndromic multiplex panels at this stage of the COVID-19 pandemic. Therefore, clinicians must have a high index of suspicion for coinfection among COVID-19 patients. Clinicians can neither rule out other co-infections caused by respiratory pathogens by diagnosing SARS-CoV-2 infection nor rule out COVID-19 by detection of non-SARS-CoV-2 respiratory pathogens. After recognizing the possible pathogens causing co-infection among COVID-19 patients, appropriate antimicrobial agents can be recommended.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · cited 2×
“11,12,14-16,18,19,21,22 Meanwhile, three of these studies were conducted in the United States (US), 13,20,22 one each in Singapore 17 and Italy.”
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246 · cited 1×
“8% received oseltamivir therapy.(41) Finally, according to the recommendation of National Institutes of Health, there are insufficient data to recommend empiric broad-spectrum antimicrobial therapy in the absence of another indication in patients with COVID19 and severe or critical illness.”
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Lai, C.-C., Shih, T.-P., Ko, W.-C., Tang, H.-J., & Hsueh, P.-R. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105924 · Cited by 6,068
Self-citationMetlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., Cooley, L. A., Dean, N. C., Fine, M. J., Flanders, S. A., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201908-1581st · Cited by 3,657 · cited 2×
“For influenza, the original recommendations in the in the ATS/IDSA CAP treatment guidelines were made for the treatment of potential bacterial co-infections.(5) As similar clinical entity of co-infection is possible with SARS-CoV-2 infections, this recommendation has been applied in the treatment of COVID-19 and has b…”
Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State
Arentz, M., Yim, E., Klaff, L., Lokhandwala, S., Riedo, F. X., Chong, M., & Lee, M. (2020) · JAMA · doi:10.1001/jama.2020.4326 · Cited by 2,259 · cited 1×
“Arentz et al.(13) United States 21 (critically ill) 3 (14.”
F. T. Z. H. O. W. U. N. C. M. A. R. T., Jin, Y.-H., Cai, L., Cheng, Z.-S., Cheng, H., Deng, T., Fan, Y.-P., Fang, C., Huang, D., Huang, L.-Q., et al. (2020) · Military Medical Research · doi:10.1186/s40779-020-0233-6 · Cited by 2,254
Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore
Young, B. E., Ong, S. W. X., Kalimuddin, S., Low, J. G., Tan, S. Y., Loh, J., Ng, O.-T., Marimuthu, K., Ang, L. W., Mak, T. M., et al. (2020) · JAMA · doi:10.1001/jama.2020.3204 · Cited by 2,059
Alhazzani, W., Møller, M. H., Arabi, Y. M., Loeb, M., Gong, M. N., Fan, E., Oczkowski, S., Levy, M. M., Derde, L., Dzierba, A., et al. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004363 · Cited by 1,565
Clinical and virological data of the first cases of COVID-19 in Europe: a case series
Lescure, F.-X., Bouadma, L., Nguyen, D., Parisey, M., Wicky, P.-H., Behillil, S., Gaymard, A., Bouscambert-Duchamp, M., Donati, F., Le Hingrat, Q., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30200-0 · Cited by 1,092
Bhimraj, A., Morgan, R. L., Shumaker, A. H., Lavergne, V., Baden, L., Cheng, V. C.-C., Edwards, K. M., Gandhi, R., Muller, W. J., O’Horo, J. C., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa478 · Cited by 1,033
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Colson, P., Rolain, J.-M., Lagier, J.-C., Brouqui, P., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105932 · Cited by 937
Uyeki, T. M., Bernstein, H. H., Bradley, J. S., Englund, J. A., File, T. M., Fry, A. M., Gravenstein, S., Hayden, F. G., Harper, S. A., Hirshon, J. M., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy866 · Cited by 795
Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens
Kim, D., Quinn, J., Pinsky, B., Shah, N. H., & Brown, I. (2020) · JAMA · doi:10.1001/jama.2020.6266 · Cited by 769
[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].
Chen, L., Liu, H., Liu, W. Y., Liu, J., Liu, K., Shang, J., Deng, Y., & Wei, S. (2020) · PubMed · doi:10.3760/cma.j.issn.1001-0939.2020.0005 · Cited by 693
Uyeki, T. M., Bernstein, H. H., Bradley, J. S., Englund, J. A., File, T. M., Fry, A. M., Gravenstein, S., Hayden, F. G., Harper, S. A., Hirshon, J. M., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy874 · Cited by 413
Ding, Q., Lu, P., Fan, Y., Xia, Y., & Liu, M. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25781 · Cited by 409
COVID-19: don't neglect antimicrobial stewardship principles!
Huttner, B. D., Catho, G., Pano-Pardo, J. R., Pulcini, C., & Schouten, J. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.04.024 · Cited by 388
Li, D., Wang, D., Dong, J., Wang, N., Huang, H., Xu, H., & Xia, C. (2020) · Korean Journal of Radiology · doi:10.3348/kjr.2020.0146 · Cited by 367
Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China
Wu, X., Cai, Y., Huang, X., Yu, X., Zhao, L., Wang, F., Li, Q., Gu, S., Xu, T., Li, Y., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2606.200299 · Cited by 330
Arguments in favour of remdesivir for treating SARS-CoV-2 infections
Ko, W.-C., Rolain, J.-M., Lee, N.-Y., Chen, P.-L., Huang, C.-T., Lee, P.-I., & Hsueh, P.-R. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105933 · Cited by 316
Self-citationSyndromic Panel-Based Testing in Clinical Microbiology
Ramanan, P., Bryson, A. L., Binnicker, M. J., Pritt, B. S., & Patel, R. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00024-17 · Cited by 308
Zangrillo, A., Beretta, L., Scandroglio, A. M., Monti, G., Fominskiy, E., Colombo, S., Morselli, F., Belletti, A., Silvani, P., Crivellari, M., et al. (2020) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)00387-3 · Cited by 249
Lee, S. H., Ruan, S.-Y., Pan, S.-C., Lee, T.-F., Chien, J.-Y., & Hsueh, P.-R. (2019) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2019.10.009 · Cited by 206
Self-citationArabi, Y. M., Al-Omari, A., Mandourah, Y., Al-Hameed, F., Sindi, A. A., Alraddadi, B., Shalhoub, S., Almotairi, A., Al Khatib, K., Abdulmomen, A., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002621 · Cited by 180
Co‐infection of SARS‐CoV‐2 and HIV in a patient in Wuhan city, China
Zhu, F., Cao, Y., Xu, S., & Zhou, M. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25732 · Cited by 179
Clinical diagnosis of 8274 samples with 2019-novel coronavirus in WuhanPreprint
Wang, M., Wu, Q., Xu, W., Qiao, B., Wang, J., Zheng, H., Jiang, S., Mei, J., Wu, Z., Deng, Y., et al. (2020) · medRxiv · doi:10.1101/2020.02.12.20022327 · Cited by 150
Recommendations and guidelines for the treatment of pneumonia in Taiwan
Chou, C.-C., Shen, C., Chen, S., Chen, H.-M., Wang, Y.-C., Chang, W., Chang, Y.-T., Chen, W.-Y., Huang, C.-Y., Kuo, C.-C., et al. (2018) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2018.11.004 · Cited by 124
Precautions Are Needed for COVID-19 Patients with Coinfection of Common Respiratory PathogensPreprint
Xing, Q., Li, G., Xing, Y., Chen, T., Li, W., Ni, W., Deng, K., Gao, R., Chen, C.-Z., Gao, Y., et al. (2020) · SSRN Electronic Journal · doi:10.1101/2020.02.29.20027698 · Cited by 118
Co-infection of Coronavirus Disease 2019 and Influenza A: A Report from Iran
Khodamoradi, Z., Moghadami, M., & Lotfi, M. (2020) · Archives of Iranian Medicine · doi:10.34172/aim.2020.04 · Cited by 110
Li, H., Chen, K., Liu, M., Xu, H., & Xu, Q. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.04.001 · Cited by 79
Panton-Valentine Leukocidin–Secreting Staphylococcus aureus Pneumonia Complicating COVID-19
Duployez, C., Guern, R. L., Tinez, C., Lejeune, A.-L., Robriquet, L., Six, S., Loïez, C., & Wallet, F. (2020) · Emerging infectious diseases · doi:10.3201/eid2608.201413 · Cited by 77
Zahariadis, G., Gooley, T. A., Ryall, P., Hutchinson, C., Latchford, M., Fearon, M. A., Jamieson, F., Richardson, S. E., Kuschak, T. I., & Mederski, B. (2006) · Canadian Respiratory Journal · doi:10.1155/2006/862797 · Cited by 74
Alfaraj, S. H., Al‐Tawfiq, J. A., Altuwaijri, T. A., & Memish, Z. A. (2017) · Intervirology · doi:10.1159/000477908 · Cited by 68
Lee, N. L. S., Chan, P. K. S., Yu, I. T. S., Tsoi, K., Lui, G. C.-Y., Sung, J. J. �., & Cockram, C. S. (2007) · Journal of Clinical Virology · doi:10.1016/j.jcv.2007.08.015 · Cited by 49
Hung, H.-M., Yang, S.-L., Chen, C., Chiu, C.-H., Kuo, C.-Y., Huang, K.-Y. A., Lin, T., Hsieh, Y. C., Gong, Y., Tsao, K., et al. (2018) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2018.08.009 · Cited by 46
Alfaraj, S. H., Al‐Tawfiq, J. A., Alzahrani, N. A., Altuwaijri, T. A., & Memish, Z. A. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.02.001 · Cited by 38
Su, I.-C., Lee, K., Liu, H.-Y., Chuang, H.-C., Chen, L., & Lee, Y. (2018) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2018.05.007 · Cited by 33
Cited by
Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., Cooley, L. A., Dean, N. C., Fine, M. J., Flanders, S. A., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201908-1581st · Cited by 3,657
Increased antimicrobial resistance during the COVID-19 pandemic
Lai, C.-C., Chen, S.-Y., Ko, W.-C., & Hsueh, P.-R. (2021) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2021.106324 · Cited by 436
Self-citationThe microbial coinfection in COVID-19
Chen, X., Liao, B., Cheng, L., Peng, X., Xu, X., Li, Y., Hu, T., Li, J., Zhou, X., & Ren, B. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10814-6 · Cited by 330
The role of co-infections and secondary infections in patients with COVID-19
Feldman, C., & Anderson, R. (2021) · Pneumonia · doi:10.1186/s41479-021-00083-w · Cited by 319
Al-Shaarani, A. A. Q. A., & Pecoraro, L. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1428415 · Cited by 50
“Besides, A. fumigatus , together with A. flavus and A. niger , have the capacity to infect tissues not only within the respiratory system, but also eyes, skin, central nervous system, and nails (Patterson et al., 2016; Tsai et al., 2019; Lai et al., 2020; Jing et al., 2022).”
Background
Metadata
- Authors
- Lai, C.-C., Wang, C.-Y., & Hsueh, P.-R.
- Venue
- Journal of Microbiology, Immunology and Infection
- Publisher
- Elsevier BV
- Published
- 2020-08
- Volume
- 53
- Issue
- 4
- Pages
- 505-512
- ISSN
- 1684-1182 (ISSN-L)
- OpenAlex
- W3026446975
- Cited by
- 489
- References
- 43
- FWCI
- 12.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.